PhD Studentship in Pancreatic Cancer Research
A bursary of £21,000 per year for 3 years plus Home/EU tuition fees. For medically qualified candidates the bursary can be supplemented by standard banding through participation in an on-call rota at Hammersmith Hospital to attract a full clinical salary at appropriate experience level.
Primary site: Hepatopancreatobiliary Surgery Unit, Division of Surgery, Department of Surgery & Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital campus, 150 Du Cane Road, White City, London W12 0HS.
Secondary site: Laboratory of Systems and Precision Cancer Medicine, Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey SM2 5NG.
Principal Supervisor: Mr Mikael Sodergren, Academic Clinical Lecturer in Surgery, Imperial College, London
1) Dr Anguraj Sadanandam, Team Leader, Laboratory of Systems and Precision Cancer Medicine, Division of Molecular Pathology, The Institute of Cancer Research, London
2) Professor Nagy Habib, Professor of Hepatobiliary Surgery, Imperial College, London
Named collaborator: Dr Jan Henrik Storkholm (Rigshospitalet, Copenhagen, Denmark);
The Hepatopancreatobiliary Surgery Unit at Imperial College London has a long history of translational research that has benefitted patients. The research programme has particular strengths in medical device
development, immuno-oncology (drug development, tumour priming, vaccination), radiofrequency ablation and clinical trials. In the most recent Research Excellence Framework assessment Imperial’s research ranked the highest for impact measure of any major university.
The case study submitted by the HPB unit on radiofrequency ablation was selected among those that have had the most “Impact on Society” and was ranked 1 with a score of 93%.
The division is a multidisciplinary team of over 160 clinicians, engineers, scientists, psychologists, policy analysts, data specialists, healthcare managers, economists, industrial designers and entrepreneurs all focused on the co- creation and diffusion of healthcare innovation. Housed within the Faculty of Medicine, we collaborate across the College’s wealth of multidisciplinary talent to innovate across science, technology, design and policy.
This full-time PhD studentship is an exciting opportunity to work on cutting edge clinical and basic science research in pancreatic cancer. The collaboration with Institute of Cancer Research ensures that the PhD student will also work in one of the leading translational science pancreatic cancer research laboratories focusing on hypothesis-driven integrated analysis of high-throughput genomics, transcriptomics and metabolomics data generated from patient tumours, transplanted and genetically engineered animal tumours and cancer cell lines, where the student will also have the opportunity to learn bioinformatics and data analysis.
The PhD project will involve pre-clinical research of novel therapeutics for pancreatic cancer and the evaluation of their role in vitro, using in vivo models and in the neoadjuvant clinical setting. The candidate will also gain experience in a clinical trial which will focus on perioperative outcomes following major hepatopancreatobiliary surgery.
The studentship is fully funded (stipend and Home/EU tuition fees) and for a medically qualified candidate attracts a banding supplement on participation in a clinical on-call rota.
The student will be registered for an Imperial College PhD degree in the Faculty of Medicine where they will be based within the Department of Surgery and Cancer. A strong and experienced multidisciplinary team of co-supervisors and collaborators, led by Mr Sodergren, will supervise the student. The student will be admitted to the Imperial College Graduate School and enjoy all the benefits thereof (https://www.imperial.ac.uk/study/pg/graduate-school/). If from a relevant professional background, they will also be encouraged to join Imperial College’s newly inaugurated Healthcare Professional Academic Group (http://www.imperial.ac.uk/department-surgery-cancer/research/surgery/healthcare-professional-academic-group/).
The successful candidate for this PhD studentship will be appointed through an open call and competition. We warmly welcome applications from excellent candidates from basic science backgrounds which are relevant to the aims of the project as well as medically qualified candidates from all specialties. The appointment will be made solely based on the academic attributes and potential of the applicants and their potential to deliver the research aims.
Should you require any further details on the role please contact Mr Mikael Sodergren – email@example.com
How to apply
In the first instance, please:
Email: Mr Sodergren with an expression of interest by 25th of February by clicking the apply button.
Your expression of interest should contain the following items:
- Your CV
- A personal statement no more than 1,000 words outlining: 1) your interest, 2) your background, and 3) which research area(s) you would like to base your project on
- Scans of your educational certificates and transcripts from your Master’s degree and your Bachelor’s degrees
- Names and contact details of 2 referees who can speak to your educational background.
- Reference letters from these referees are ideal, but not required at this stage.
Shortlisted candidates will be informed via email and will be interviewed.
Successful candidates will be required to formally apply through the Imperial College London Postgraduate Research (PhD) Programme route.
Closing date: 5 March 2019
Apply for PhD Studentship in Pancreatic Cancer Research
Already uploaded your CV? Sign in to apply instantly